ARCHIVES

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting

March 12, 1982

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013

CCIRC Holds Groups To 1980 Spending Levels, But They May Get Even Less

January 9, 1981

Data collection Completed In NCI Study of BRACA1

August 16, 1996

DRCCA Board Gives Concept Approval To Nutrition Clinical Trials Which Could Total $52.5 Million

January 28, 1983

Bristol-Myers Survey Predicts Year 2000 Survival of 66%

April 3, 1987